How Long Has Praluent Been on the Market?
Praluent (alirocumab) was FDA approved July 24, 2015, and has been on the market over 9 years, with a cardiovascular indication added in April 2019.
Alirocumab: Regulatory History
1 source-based articles maintained by the HealthRX.com Editorial Team.
1articles
1topic areas covered
May 25, 2026latest review
Alirocumab: Regulatory History library
Showing 1 of 1 clinical reviews.